Literature DB >> 23317211

Standardized breast cancer mortality rate compared to the general female population of Iran.

S Haghighat1, M E Akbari, S Ghaffari, P Yavari.   

Abstract

INTRODUCTION: Breast cancer is the most common cancer in women. Improvements of early diagnosis modalities have led to longer survival rates. This study aimed to determine the 5, 10 and 15 year mortality rates of breast cancer patients compared to the normal female population.
MATERIALS AND METHODS: The follow up data of a cohort of 615 breast cancer patients referred to Iranian Breast Cancer Research Center (BCRC) from 1986 to 1996 was considered as reference breast cancer dataset. The dataset was divided into 5 year age groups and the 5, 10 and 15 year probability of death for each group was estimated. The annual mortality rate of Iranian women was obtained from the Death Registry system. Standardized mortality ratios (SMRs) of breast cancer patients were calculated using the ratio of the mortality rate in breast cancer patients over the general female population.
RESULTS: The mean age of breast cancer patients at diagnosis time was 45.9 (±10.5) years ranging from 24-74. A total of 73, 32 and 2 deaths were recorded at 5, 10 and 15 years, respectively, after diagnosis. The SMRs for breast cancer patients at 5, 10 and 15 year intervals after diagnosis were 6.74 (95% CI, 5.5- 8.2), 6.55 (95%CI, 5-8.1) and 1.26 (95%CI, 0.65-2.9), respectively.
CONCLUSION: Results showed that the observed mortality rate of breast cancer patients after 15 years from diagnosis was very similar to expected rates in general female population. This finding would be useful for clinicians and health policy makers to adopt a beneficial strategy to improve breast cancer survival. Further follow-up time with larger sample size and a pooled analysis of survival rates of different centres may shed more light on mortality patterns of breast cancer.

Entities:  

Mesh:

Year:  2012        PMID: 23317211     DOI: 10.7314/apjcp.2012.13.11.5525

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Inhibitory and Cytotoxic Activities of Chrysin on Human Breast Adenocarcinoma Cells by Induction of Apoptosis.

Authors:  Saeed Samarghandian; Mohsen Azimi-Nezhad; Abasalt Borji; Malihe Hasanzadeh; Farahzad Jabbari; Tahereh Farkhondeh; Mohammad Samini
Journal:  Pharmacogn Mag       Date:  2016-07       Impact factor: 1.085

2.  Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.

Authors:  Amir Ansaripour; Carin A Uyl-de Groot; W Ken Redekop
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981

3.  The Investigation of Risk Factors Impacting Breast Cancer in Guilan Province

Authors:  Farahnaz Joukar; Zahra Ahmadnia; Zahra Atrkar-Roushan; Farideh Hasavari; Abbas Rahimi
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

4.  OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients.

Authors:  Fan Yang; Jiaming Zhang; Hua Yang
Journal:  Onco Targets Ther       Date:  2018-11-06       Impact factor: 4.147

5.  Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.

Authors:  Shahpar Haghighat; Mohammad Esmaeil Akbari; Parvin Yavari; Mehdi Javanbakht; Shahram Ghaffari
Journal:  Iran J Cancer Prev       Date:  2016-02-23

6.  Survival Analysis of Breast Cancer Patients after Surgery with an Intermediate Event: Application of Illness-Death Model.

Authors:  Morteza Hajihosseini; Javad Faradmal; Abdolazim Sadighi-Pashaki
Journal:  Iran J Public Health       Date:  2015-12       Impact factor: 1.429

Review 7.  Awareness and current knowledge of breast cancer.

Authors:  Muhammad Akram; Mehwish Iqbal; Muhammad Daniyal; Asmat Ullah Khan
Journal:  Biol Res       Date:  2017-10-02       Impact factor: 5.612

8.  Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014.

Authors:  Mohammad Esmaeil Akbari; Soheila Sayad; Saed Sayad; Maryam Khayamzadeh; Leila Shojaee; Zeynab Shormeji; Mojtaba Amiri
Journal:  Int J Breast Cancer       Date:  2017-11-01

9.  Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data

Authors:  Ahmad Reza Baghestani; Parviz Shahmirzalou; Soheila Sayad; Mohammad Esmaeil Akbari; Farid Zayeri
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

10.  Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran.

Authors:  Roya Dolatkhah; Mohammad Hossein Somi; Mohammad Asghari Jafarabadi; Mehrnaz Hosseinalifam; Sepideh Sepahi; Mina Belalzadeh; Marzieh Nezamdoust; Saeed Dastgiri
Journal:  Int J Breast Cancer       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.